JULIE ROBINSON: Open Payments
NPI 1285418244 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,795 in 84 payments from 18 companies in 2025. Trend: 2023 $389 · 2024 $1,730 · 2025 $1,795
Food & beverage: $1,795
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $487 |
| ABBVIE INC. | 14 | $345 |
| Vanda Pharmaceuticals Inc. | 9 | $243 |
| Alkermes, Inc. | 13 | $163 |
| Otsuka America Pharmaceutical, Inc. | 7 | $145 |
| Lundbeck LLC | 3 | $76 |
| Corium, LLC | 4 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| Axsome Therapeutics, Inc. | 3 | $55 |
| Lilly USA, LLC | 1 | $24 |
Products named: CAPLYTA, VRAYLAR, HETLIOZ, REXULTI, LYBALVI, Azstarys, ARISTADA, TRINTELLIX.
Industry payments across KY — which companies pay providers there.
